GSK Faces New Round of Corruption Claims - This Time in Iraq
GSK is investigating allegations that its staff in Iraq have bribed physicians to use Glaxo products
GlaxoSmithKline Sacks Staff on China Bribery Scandal
Doctors are accused of routing 3bn yuan in bribes to doctors through travel agencies and consultancies
Diet Pill Alli Pulled From US and Puerto Rico Shelves
GlaxoSmithKline voluntarily recalls popular weight loss pills after tampering
GlaxoSmithKline Boss Beats Rolls Royce and John Lewis Chiefs to Top CEO League Table
Andrew Witty, chief executive from 2008, given a staggering 100% approval rating by his staff.
Sanofi Fined €28m in Germany as Two Former Employees Convicted of Bribery
Former Sanofi employees had made illicit payments to win more orders between 2007 and 2010.
Brain-Damaged UK Victims of Swine Flu Vaccine to Get £60 Million Compensation
Children who reacted badly to vaccine now suffer from debilitating sleep disorder narcolepsy.
GlaxoSmithKline Shaves Bonuses on Bribery Scandal
GlaxoSmithKline has cut senior executive bonus payments after a wide scale investigation in China revealed that high level staff had bribed doctors for business.
GlaxoSmithKline Shaves Bonuses on China Bribery Scandal
China accused unnamed GSK executives of routing 3bn yuan ($488m, £307m, €365m) in bribes to doctors
European Markets Rise on Strong Eurozone PMI Data
Investors await GlaxoSmithKline Q4 earnings update due at 12.00 GMT.
Round up of the Year: Top 12 Science Stories from 2013
IBTimes UK looks at the biggest science stories from the last 12 months.
GlaxoSmithKline to End Payments to Doctors to Promote Drugs
Company will end sales staff bonus payment system, based on number of prescriptions written by doctors
European Markets Rise Amid Federal Reserve QE Taper Uncertainty
The US Fed's FOMC will meet on 17-18 December.
Asian Markets Down on China Data and Federal Reserve QE Taper Jitters
US Federal Reserve's FOMC will meet on 17-18 December.
GlaxoSmithKline to Increase Stake in Indian Unit With $1bn Open Offer
Move indicates that GSK is more reliant on high-growth emerging markets than traditional western markets.
GlaxoSmithKline Pledges £200m To Upgrade UK Production Sites
Britain's "Patent Box" tax breaks motivate GSK to invest more in UK.
Scottish Independence: Will Salmond's 'Braveheart' History Triumph?
There will be plenty of political debate over Scottish independence but, in the end, it comes down to emotions.
GlaxoSmithKline Eyes £25m Scottish Expansion and Jobs Boost
The pharmaceutical giant GSK's move will create 25 new jobs in Montrose.
China's Bribery Culture Poses Massive Risks for Multinational Companies
Officials in the United States and China probe numerous cases involving multinationals and bribery in China.
Germany's Merck Spends €80m on China Manufacturing Facility
Merck looks to capitalise on China, which is set to become second-biggest drugs market behind US by 2016.
GlaxoSmithKline to Escape China Bribery Charges as Individual Executives Blamed
Reports say the company and Briton Mark Reilly, GSK's former head of China operations, will escape charges
Danone to Rejig Dumex Management in China Amid Bribery Charges
Chinese unit Dumex accused of bribing doctors to boost infant-formula sales.
GSK Aims To Market Worlds First Malaria Vaccine
British drug-maker GlaxoSmithKline will seek marketing approval for the world's first malaria vaccine next year after trial data showed the shot significantly cut cases of the disease in African children.
GlaxoSmithKline Unveils World's First Malaria Vaccine that Will Save 'Millions'
Hundreds of thousands of lives to be saved after malaria vaccine is rolled out in two years.
China, Malaysia, Indonesia and Vietnam World's Worst for Bribery and Corruption
Ernst & Young report reveals Asia has the worst defences against corporate fraud of any region.
Powerful Whistleblower Attorney: US Protection and Bounty System Helps Root Out Financial Scandal [VIDEO]
Reuben Guttman says the UK could learn a lot from the US system that protects and rewards whistleblowers
Powerful Whistleblower Attorney: US Protection and Bounty System Helps Root Out Financial Scandal
The only way to prevent and root out large scale financial and company scandals is by installing bounty programmes and protection systems in place that reward those who risk their careers to flag up wrongdoing, says one of the world's most prominent
GSK Whistleblower Attorney: China's Pharmaceutical Bribery Scandal is 'Tip of the Iceberg' [VIDEO]
Reuben Guttman warns that GlaxoSmithKline repercussions will hit US.
GSK Whistleblower Attorney: China's Pharmaceutical Bribery Scandal is 'Tip of the Iceberg'
Reuben Guttman represented one of the four main whistleblowers in a case against GSK that returned over $3bn to the government and here he speaks with IBTimes UK exclusively.
GlaxoSmithKline Bribery Scandal: China Crackdown on Pharmaceutical Corruption Hits Sales
GSK sales growth expected to slow down or turn negative in third quarterr.
German Drugmaker Bayer Probed in China for Unfair Competition
Bayer is latest addition to group of foreign firms facing probe in China, including British drugmaker GlaxoSmithKline.